Literature DB >> 33662428

Unravelling the involvement of gut microbiota in type 2 diabetes mellitus.

Arpita Arora1, Tapan Behl2, Aayush Sehgal1, Sukhbir Singh1, Neelam Sharma1, Saurabh Bhatia3, Eduardo Sobarzo-Sanchez4, Simona Bungau5.   

Abstract

Type 2 diabetes mellitus is the most prevalent metabolic disorder characterized by hyperglycemia, hyperlipidemia as well as insulin resistance and is affecting the lives of a huge population across the globe. Genetic mutations, obesity and lack of physical activity constitute the possible factors that can lead to onset and progression of this disorder. However, there is another major factor that can be the root cause of type 2 diabetes mellitus and that is an imbalance in the microorganisms that inhabit the gut. The gut microbiome is a vital component that needs to be given significant attention because any "dysbiosis" in the colonic microorganisms can transform the host from a state of health to a state of disease. This transformation is quite obvious since the gut barrier integrity, host metabolism such as sensitivity to insulin and maintaining blood glucose level are carried out by the tiny organisms inhabiting our intestine. In fact, the normal functioning of the human body is accredited to the microbes, particularly the bacteria, because they generate their metabolites that communicate with host cells and maintain normal physiology. Giving importance to gut health is, therefore, necessary to prevent metabolic diseases that can be maintained by the intake of prebiotics, probiotics, synbiotics along with healthy diet. The tiny microorganisms in the gut that keep our body free of disorders such as type 2 diabetes mellitus need to be in a state of 'eubiosis', else the consequences of disturbance in gut microbes can progress to serious complications in the host.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gut microbiome; Metabolic disorder; Microbiota dysfunction; Type 2 diabetes mellitus

Mesh:

Year:  2021        PMID: 33662428     DOI: 10.1016/j.lfs.2021.119311

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  An Open-Label Trial Study of Quality-of-Life Assessment in Irritable Bowel Syndrome and Their Treatment.

Authors:  Bogdana Ariana Alexandru; Lavinia Alina Rat; Andrada Florina Moldovan; Petru Mihancea; Lavinia Mariș
Journal:  Medicina (Kaunas)       Date:  2022-06-05       Impact factor: 2.948

Review 2.  Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients.

Authors:  Golnoosh Mahjoob; Yasin Ahmadi; Huda Fatima Rajani; Nafiseh Khanbabaei; Sakhavat Abolhasani
Journal:  J Clin Lab Anal       Date:  2022-03-29       Impact factor: 3.124

Review 3.  Pyrroloquinoline-Quinone Is More Than an Antioxidant: A Vitamin-like Accessory Factor Important in Health and Disease Prevention.

Authors:  Karen R Jonscher; Winyoo Chowanadisai; Robert B Rucker
Journal:  Biomolecules       Date:  2021-09-30

4.  Water Kefir and Derived Pasteurized Beverages Modulate Gut Microbiota, Intestinal Permeability and Cytokine Production In Vitro.

Authors:  Marta Calatayud; Rosa Aragao Börner; Jonas Ghyselinck; Lynn Verstrepen; Jelle De Medts; Pieter Van den Abbeele; Claire L Boulangé; Sarah Priour; Massimo Marzorati; Sami Damak
Journal:  Nutrients       Date:  2021-10-29       Impact factor: 5.717

5.  Inflammatory bowel disease and diabetes: Is there a link between them?

Authors:  Miao-Miao Sang; Zi-Lin Sun; Tong-Zhi Wu
Journal:  World J Diabetes       Date:  2022-02-15

6.  Unraveling Gut Microbiota Signatures Associated with PPARD and PARGC1A Genetic Polymorphisms in a Healthy Population.

Authors:  María Bailén; Mariangela Tabone; Carlo Bressa; María Gregoria Montalvo Lominchar; Mar Larrosa; Rocío González-Soltero
Journal:  Genes (Basel)       Date:  2022-02-01       Impact factor: 4.096

7.  Excessive Intake of High-Fructose Corn Syrup Drinks Induces Impaired Glucose Tolerance.

Authors:  Hidemi Hattori; Yuma Hanai; Yuto Oshima; Hiroaki Kataoka; Nozomu Eto
Journal:  Biomedicines       Date:  2021-05-12

8.  Glucosamine Ameliorates Symptoms of High-Fat Diet-Fed Mice by Reversing Imbalanced Gut Microbiota.

Authors:  Xubing Yuan; Junping Zheng; Lishi Ren; Siming Jiao; Cui Feng; Yuguang Du; Hongtao Liu
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

Review 9.  Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium.

Authors:  Raluca Anca Corb Aron; Areha Abid; Cosmin Mihai Vesa; Aurelia Cristina Nechifor; Tapan Behl; Timea Claudia Ghitea; Mihai Alexandru Munteanu; Ovidiu Fratila; Felicia Liana Andronie-Cioara; Mirela Marioara Toma; Simona Bungau
Journal:  Microorganisms       Date:  2021-03-17

Review 10.  Effects of Probiotic Supplementation on Inflammatory Markers and Glucose Homeostasis in Adults With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Li-Na Ding; Wen-Yu Ding; Jie Ning; Yao Wang; Yan Yan; Zhi-Bin Wang
Journal:  Front Pharmacol       Date:  2021-12-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.